Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Imukin

This product is the most expensive of its product family


Contraindicated
Reproductive toxicity in animals

Contraindicated
Imukin :
Type Medicine Authorised
Originator Biotech (Actemra 200mg)
Agent BroadMed
Distributor BroadMed
Laboratory Clinigen
Responsible Party Boehringer Ingelheim Pharma GmbH & Co KG
Origin Germany
Manufacturer Boehringer Ingelheim Pharma GmbH & Co KG
Origin Germany
ATC L03AB03

Your comment will appear shortly after approval


Different Units By MoH Code

Imukin  MoH 3348 :
Form Suspension for injection
Packaging Bottle
Package Size 1 x0.5ml
Strength 100µg
Public Price 6145432.35 L.L.
Stratum B
NSSF
Quarantine
Reg. Number 195076/04
Submission date 01/01/2004
Registration Year 2005
Archived Date 2018





Price Comparison

Country: Oman
Package Size: 1x0,5ml
Public Price: 56.94 OMR ( 13,137,993.96 LBP )
Pack size unit used: 1
Cost/Unit: 56,94 OMR ( 12,921,104.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: Italy
Package Size: 6x0,5ml
Public Price: 761.09 EUR ( 73,731,354.84 LBP )
Pack size unit used: 6
Cost/Unit: 126,8483 EUR ( 12,206,376.00 LBP )
Exfactory Price: 461.16 EUR
Pricing Date: 17/12/2019
Type: Medicine Authorised

Country: Norway
Package Size: 6x0,5ml
Public Price: 8777.6 NOK ( 71,133,670.40 LBP )
Pack size unit used: 6
Cost/Unit: 1462,9333 NOK ( 11,848,048.00 LBP )
Pharmacy Price: 6822.51 NOK ( 55289621.04 LBP )
Reference: Norwegian Medicine Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Spain
Package Size: 1x0,5ml
Public Price: 122.55 EUR ( 11,872,153.80 LBP )
Pack size unit used: 1
Cost/Unit: 122,55 EUR ( 11,818,872.00 LBP )
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Authorised

Country: France
Package Size: 1x0,5ml
Public Price: 116 EUR ( 11,237,616.00 LBP )
Pack size unit used: 1
Cost/Unit: 116 EUR ( 11,237,616.00 LBP )
Reference: ansm
Pricing Date: 15/05/2021
Type: Medicine Authorised

Country: KSA
Package Size: 1x0.5ml
Public Price: 469.15 SAR ( 11,090,706.00 LBP )
Pack size unit used: 1
Cost/Unit: 469,15 SAR ( 11,087,160.00 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: Jordan
Package Size: 1x0,5ml
Public Price: 83.19 JOD ( 10,417,134.99 LBP )
Pack size unit used: 1
Cost/Unit: 83,19 JOD ( 10,393,343.00 LBP )
Reference: JFDA
Pricing Date: 12/12/2018
Type: Medicine Non Marketed

Country: Greece
Package Size: 1x0,5ml
Public Price: 102.04 EUR ( 9,885,227.04 LBP )
Pack size unit used: 1
Cost/Unit: 102,04 EUR ( 9,881,352.00 LBP )
Exfactory Price: 76.47 EUR
Pharmacy Price: 80.22 EUR ( 7771392.72 LBP )
Reference: National Organization for Medicines
Pricing Date: 25/03/2019
Type: Medicine Non Marketed

Country: Belgium
Package Size: 6
Public Price: 536.78 EUR ( 52,001,099.28 LBP )
Pack size unit used: 6
Cost/Unit: 89,4633 EUR ( 8,621,964.00 LBP )
Reference: cbip
Pricing Date: 18/05/2018
Type: Medicine Non Marketed

Country: Ireland
Package Size: 6x0.5ml
Public Price: 447.36 EUR ( 43,338,447.36 LBP )
Pack size unit used: 6
Cost/Unit: 74,56 EUR ( 7,168,824.00 LBP )
Pricing Date: 11/02/2019
Type: Medicine Non Marketed

Country: Sweden
Package Size: 6x0,5ml
Public Price: 5047.75 SEK ( 42,441,482.00 LBP )
Pack size unit used: 6
Cost/Unit: 841,2917 SEK ( 7,071,128.00 LBP )
Pharmacy Price: 4903.43 SEK ( 41228039.44 LBP )
Pricing Date: 13/07/2018
Type: Medicine Non Marketed

Country: Lebanon
Form: Suspension for injection
Package Size: 1 x0.5ml
Public Price: 6145432.35 LBP ( 6,145,432.35 LBP )
Pack size unit used: 1
Cost/Unit: 6145432,35 LBP ( 6,145,432.00 LBP )
Pricing Date: 13/06/2024

Country: Qatar
Package Size: 1x0,5ml
Public Price: 245 QAR ( 6,016,710.00 LBP )
Pack size unit used: 1
Cost/Unit: 245 QAR ( 6,016,710.00 LBP )
Pharmacy Price: 201.11 QAR ( 4938859.38 LBP )
Pricing Date: 20/07/2017
Type: Medicine Non Marketed

Country: Abu Dhabi
Package Size: 1x0,5ml
Public Price: 242 AED ( 5,846,962.00 LBP )
Pack size unit used: 1
Cost/Unit: 242 AED ( 5,846,962.00 LBP )
Pharmacy Price: 194.9 AED ( 4708978.9 LBP )
Pricing Date: 27/01/2021
Type: Medicine Authorised

Country: UAE
Package Size: 1x0.5ml Vial
Public Price: 242 AED ( 5,846,962.00 LBP )
Pack size unit used: 1
Cost/Unit: 242 AED ( 5,846,962.00 LBP )
Pharmacy Price: 194.9 AED ( 4708978.9 LBP )
Pricing Date: 21/08/2019
Type: Medicine Authorised

Country: Denmark
Package Size: 6x0,5ml
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 56,94 OMR ( 12,921,104.00 LBP )
Cost/Day: 56,94 OMR ( 12,921,104.00 LBP )
Cost/Month: 683,28 OMR ( 157,591,322.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 56,94 OMR ( 12,921,104.00 LBP )
Cost/Day: 56,94 OMR ( 12,921,104.00 LBP )
Cost/Month: 683,28 OMR ( 157,591,322.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 126,8483 EUR ( 12,206,376.00 LBP )
Cost/Day: 126,85 EUR ( 12,206,376.00 LBP )
Cost/Month: 1522,2 EUR ( 147,445,272.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 126,8483 EUR ( 12,206,376.00 LBP )
Cost/Day: 126,85 EUR ( 12,206,376.00 LBP )
Cost/Month: 1522,2 EUR ( 147,445,272.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 1462,9333 NOK ( 11,848,048.00 LBP )
Cost/Day: 1462,93 NOK ( 11,848,048.00 LBP )
Cost/Month: 17555,16 NOK ( 142,265,720.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 1462,9333 NOK ( 11,848,048.00 LBP )
Cost/Day: 1462,93 NOK ( 11,848,048.00 LBP )
Cost/Month: 17555,16 NOK ( 142,265,720.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 122,55 EUR ( 11,818,872.00 LBP )
Cost/Day: 122,55 EUR ( 11,818,872.00 LBP )
Cost/Month: 1470,6 EUR ( 142,407,720.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 122,55 EUR ( 11,818,872.00 LBP )
Cost/Day: 122,55 EUR ( 11,818,872.00 LBP )
Cost/Month: 1470,6 EUR ( 142,407,720.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 116 EUR ( 11,237,616.00 LBP )
Cost/Day: 116 EUR ( 11,237,616.00 LBP )
Cost/Month: 1392 EUR ( 134,851,392.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 116 EUR ( 11,237,616.00 LBP )
Cost/Day: 116 EUR ( 11,237,616.00 LBP )
Cost/Month: 1392 EUR ( 134,851,392.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 469,15 SAR ( 11,087,160.00 LBP )
Cost/Day: 469,15 SAR ( 11,087,160.00 LBP )
Cost/Month: 5629,8 SAR ( 133,069,560.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 469,15 SAR ( 11,087,160.00 LBP )
Cost/Day: 469,15 SAR ( 11,087,160.00 LBP )
Cost/Month: 5629,8 SAR ( 133,069,560.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 83,19 JOD ( 10,393,343.00 LBP )
Cost/Day: 83,19 JOD ( 10,393,343.00 LBP )
Cost/Month: 998,28 JOD ( 124,970,558.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 83,19 JOD ( 10,393,343.00 LBP )
Cost/Day: 83,19 JOD ( 10,393,343.00 LBP )
Cost/Month: 998,28 JOD ( 124,970,558.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 102,04 EUR ( 9,881,352.00 LBP )
Cost/Day: 102,04 EUR ( 9,881,352.00 LBP )
Cost/Month: 1224,48 EUR ( 118,576,224.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 102,04 EUR ( 9,881,352.00 LBP )
Cost/Day: 102,04 EUR ( 9,881,352.00 LBP )
Cost/Month: 1224,48 EUR ( 118,576,224.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 89,4633 EUR ( 8,621,964.00 LBP )
Cost/Day: 89,46 EUR ( 8,621,964.00 LBP )
Cost/Month: 1073,52 EUR ( 103,947,948.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 89,4633 EUR ( 8,621,964.00 LBP )
Cost/Day: 89,46 EUR ( 8,621,964.00 LBP )
Cost/Month: 1073,52 EUR ( 103,947,948.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 74,56 EUR ( 7,168,824.00 LBP )
Cost/Day: 74,56 EUR ( 7,168,824.00 LBP )
Cost/Month: 894,72 EUR ( 86,607,144.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 74,56 EUR ( 7,168,824.00 LBP )
Cost/Day: 74,56 EUR ( 7,168,824.00 LBP )
Cost/Month: 894,72 EUR ( 86,607,144.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 841,2917 SEK ( 7,071,128.00 LBP )
Cost/Day: 841,29 SEK ( 7,071,128.00 LBP )
Cost/Month: 10095,48 SEK ( 84,878,760.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 841,2917 SEK ( 7,071,128.00 LBP )
Cost/Day: 841,29 SEK ( 7,071,128.00 LBP )
Cost/Month: 10095,48 SEK ( 84,878,760.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 6145432,35 LBP ( 6,145,432.00 LBP )
Cost/Day: 6145432,35 LBP ( 6,145,432.00 LBP )
Cost/Month: 73745188,2 LBP ( 73,745,188.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 6145432,35 LBP ( 6,145,432.00 LBP )
Cost/Day: 6145432,35 LBP ( 6,145,432.00 LBP )
Cost/Month: 73745188,2 LBP ( 73,745,188.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 245 QAR ( 6,016,710.00 LBP )
Cost/Day: 245 QAR ( 6,016,710.00 LBP )
Cost/Month: 2940 QAR ( 72,200,520.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 245 QAR ( 6,016,710.00 LBP )
Cost/Day: 245 QAR ( 6,016,710.00 LBP )
Cost/Month: 2940 QAR ( 72,200,520.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 242 AED ( 5,846,962.00 LBP )
Cost/Day: 242 AED ( 5,846,962.00 LBP )
Cost/Month: 2904 AED ( 70,163,544.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 242 AED ( 5,846,962.00 LBP )
Cost/Day: 242 AED ( 5,846,962.00 LBP )
Cost/Month: 2904 AED ( 70,163,544.00 LBP )
Reduction of the frequency of serious infections in patients with chronic Granulomatous Disease : (Adults)
Cost/Unit: 242 AED ( 5,846,962.00 LBP )
Cost/Day: 242 AED ( 5,846,962.00 LBP )
Cost/Month: 2904 AED ( 70,163,544.00 LBP )
Reduction of the frequency of serious infections in patients with severe malignant osteopetrosis : (Adults)
Cost/Unit: 242 AED ( 5,846,962.00 LBP )
Cost/Day: 242 AED ( 5,846,962.00 LBP )
Cost/Month: 2904 AED ( 70,163,544.00 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info